Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

In June and July 2016 MSF has been conducting vaccination campaigns in several refugee camps and settlements in Greece, targeting more than 4,600 children under fifteen years of age. This campaign aims at protecting refugee children with 10 antigens and preventing diseases such as pneumonia, which is the leading cause of childhood death. MSF calls on Pfizer and GSK to drop the price of the pneumonia vaccine (PCV) for governments and humanitarian organizations in emergency contexts. Photograph by Sophia Apostolia
Press release
Press release |
14 November 2016
Vaccines

MSF welcomes Pfizer’s pneumonia vaccine price reduction for children in humanitarian emergencies

In New York, on Word Pneumonia Day 2015 (Nov 12), MSF volunteers attempted to deliver more than $17 million of fake cash - the equivalent of one day of profits from the pneumonia vaccines for Pfizer globally - to Pfizer's CEO Ian Read. The same day, MSF launched a global petition to ask Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumococcal vaccine to $5 dollars per child (for all three doses) in developing countries. Photograph by Edwin Torres Photograph by Edwin Torres
Press release
Press release |
11 November 2016
Vaccines

Breaking news: Pfizer drops the price of the pneumonia vaccine for humanitarian organizations

Simphiwe holds his first delamanid tablets, which have now been included into his treatment regimen for XDR-TB, October 2016. Photograph by Sydelle Willow Smith
Press release
Press release |
26 October 2016
Tuberculosis

MSF reports on use of the new TB drugs bedaquiline and delamanid

MSF treats more than 200,000 people worldwide for HIV and 97 percent of the antiretrovirals are quality, affordable generics from India. Here, an MSF doctor in Kenya consults one MSF’s thousands of HIV+ patients under treatment. Photograph by Olga Victorie
Press release
Press release |
14 October 2016
Intellectual property and trade

In lead-up to RCEP trade deal negotiations in China, MSF urges countries not to trade away access to medicines

TB doctor Irma Davitadze at work at the Regional Center of Infectious Pathology, AIDS and Tuberculosis in Batumi, a beach resort town on the Black Sea. MSF has worked here since 2014. Photograph by Daro Sulakauri Photograph by Daro Sulakauri
Press release
Press release |
13 October 2016
Tuberculosis

MSF response to 2016 WHO Global TB Report

A man holds antiretroviral drugs at an activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015. Photograph by Stefan Heunis
Press release
Press release |
27 September 2016
Intellectual property and trade
South Africa

South Africa: No more delays Minister Davies – we need medicines

5 min
Drug-resistant patient showing daily drug dose Photograph by Sami Siva
Press release
Press release |
21 September 2016
Antimicrobial resistance

MSF Statement on Political Declaration of the United Nations General Assembly High-Level Meeting on Antimicrobial Resistance

3 min
Fizi healthzone, South Kivu, Democratic Republic of Congo, November 14, 2010. Photograph by Haavar Karlsen Photograph by Haavar Karlsen
Press release
Press release |
20 September 2016
Vaccines

MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury